Big Pharma gains as U.S. weighs cutting 340B drug discounts
Seeking Alpha ·
Leading drugmakers traded higher on Thursday after the Trump administration proposed to reduce payment rates for drugs purchased under a federal program that benefits uninsured and low-income patients. The upsurge came after the Centers for Medicare & Medicaid Services on Thursday announced
DYAX Investor Sentiment
Bullish (Long) 52% · Bearish (Short) 48%
211 participants
Related News
- SAP SE (SAP) Among Jefferies’ Top European Software Stock Picks
- Kyndryl Expands Sovereignty Solutioning with Microsoft (MSFT)
- Microsoft vs. Nvidia: Which Is the Better AI Stock to Own for the Next 3 Years?
- 7-Eleven sues Nike over Air Max 95 stripe design
- Bullish sentiment falls sharply while bearish views rise, AAII survey shows
- A $200 Billion IPO Wave Could Wipe Out $1 Trillion in Stock Market Value. What Investors Need to Know.